To include your compound in the COVID-19 Resource Center, submit it here.

GSK exercises option from Five Prime

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) exercised its option to license drug candidates discovered as part of a

Read the full 165 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE